DekaBank Deutsche Girozentrale’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-54,300
| Closed | -$199K | – | 1268 |
|
|
2019
Q3 | $199K | Sell |
54,300
-54,300
| -50% | -$199K | ﹤0.01% | 857 |
|
|
2019
Q2 | $289K | Buy |
108,600
+42,300
| +64% | +$113K | ﹤0.01% | 976 |
|
|
2019
Q1 | $211K | Buy |
66,300
+12,000
| +22% | +$38.2K | ﹤0.01% | 1032 |
|
|
2018
Q4 | $77K | Sell |
54,300
-12,000
| -18% | -$17K | ﹤0.01% | 1099 |
|
|
2018
Q3 | $211K | Sell |
66,300
-2,000
| -3% | -$6.37K | ﹤0.01% | 1054 |
|
|
2018
Q2 | $195K | Hold |
68,300
| – | – | ﹤0.01% | 1050 |
|
|
2018
Q1 | $253K | Sell |
68,300
-1,500
| -2% | -$5.56K | ﹤0.01% | 961 |
|
|
2017
Q4 | $341K | Hold |
69,800
| – | – | ﹤0.01% | 883 |
|
|
2017
Q3 | $341K | Hold |
69,800
| – | – | ﹤0.01% | 889 |
|
|
2017
Q2 | $314K | Hold |
69,800
| – | – | ﹤0.01% | 896 |
|
|
2017
Q1 | $299K | Sell |
69,800
-6,000
| -8% | -$25.7K | ﹤0.01% | 809 |
|
|
2016
Q4 | $309K | Buy |
75,800
+5,500
| +8% | +$22.4K | ﹤0.01% | 753 |
|
|
2016
Q3 | $557K | Hold |
70,300
| – | – | 0.01% | 646 |
|
|
2016
Q2 | $551K | Buy |
70,300
+11,700
| +20% | +$91.7K | 0.01% | 669 |
|
|
2016
Q1 | $441K | Sell |
58,600
-11,000
| -16% | -$82.8K | 0.01% | 679 |
|
|
2015
Q4 | $749K | Buy |
69,600
+1,000
| +1% | +$10.8K | 0.01% | 614 |
|
|
2015
Q3 | $474K | Buy |
68,600
+13,000
| +23% | +$89.8K | 0.01% | 704 |
|
|
2015
Q2 | $493K | Buy |
55,600
+2,000
| +4% | +$17.7K | 0.01% | 704 |
|
|
2015
Q1 | $528K | Buy |
53,600
+1,200
| +2% | +$11.8K | 0.01% | 703 |
|
|
2014
Q4 | $644K | Sell |
52,400
-4,600
| -8% | -$56.5K | 0.01% | 639 |
|
|
2014
Q3 | $569K | Sell |
57,000
-268,500
| -82% | -$2.68M | 0.01% | 630 |
|
|
2014
Q2 | $2.46M | Buy |
325,500
+266,000
| +447% | +$2.01M | 0.04% | 381 |
|
|
2014
Q1 | $196K | Buy |
59,500
+4,500
| +8% | +$14.8K | ﹤0.01% | 721 |
|
|
2013
Q4 | $179K | Buy |
55,000
+1,000
| +2% | +$3.26K | ﹤0.01% | 676 |
|
|
2013
Q3 | $163K | Buy |
54,000
+1,500
| +3% | +$4.53K | ﹤0.01% | 687 |
|
|
2013
Q2 | $433K | Buy |
+52,500
| New | +$433K | 0.01% | 465 |
|